The role of m5C RNA modification in cancer development and therapy

Li Yu1, Hongen Xu2,3, Hanchu Xiong3

  • 1Cancer Center, Department of Nursing, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.

Heliyon
|October 24, 2024
PubMed

Insights

This review focuses on 5-cytosine methylation (m5C) RNA modifications, exploring their roles in cancer development and progression. Targeting m5C regulators may offer new cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Oncology

Background:

  • RNA modifications influence RNA function, stability, processing, and interactions.
  • Various RNA methylation types, including m6A, m5C, m7G, m6Am, and m1A, are implicated in tumorigenesis.
  • While m6A's role in cancer is established, m5C's functions require further elucidation.

Purpose of the Study:

  • To describe the biological functions of 5-cytosine methylation (m5C) RNA modifications in tumorigenesis and tumor progression.
  • To highlight the molecular mechanisms underlying m5C RNA modification in oncogenesis.
  • To discuss the potential of targeting m5C regulator-associated genes as a novel cancer therapeutic strategy.

Main Methods:

  • Literature review of existing studies on m5C RNA modifications.
  • Analysis of molecular mechanisms linking m5C to cancer.
  • Discussion of therapeutic implications of targeting m5C regulators.

Main Results:

  • m5C RNA modifications play significant roles in cancer development and progression.
  • Specific molecular pathways involving m5C regulators in oncogenesis were identified.
  • Targeting m5C regulators presents a promising avenue for cancer therapy.

Conclusions:

  • m5C RNA modifications are critical players in cancer biology.
  • Understanding m5C mechanisms provides insights into oncogenesis.
  • Targeting m5C regulators offers a potential novel therapeutic strategy for cancer patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K